123 related articles for article (PubMed ID: 50675)
1. [Treatment of erythema nodosum with an estrogen-gestagen hormonal preparation].
Spirov G; Vetsova N
Vestn Dermatol Venerol; 1975 Feb; (2):57-8. PubMed ID: 50675
[No Abstract] [Full Text] [Related]
2. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
Krause W; Böhm W; Müller W
Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
[No Abstract] [Full Text] [Related]
3. [Serum enzyme examinations in the climacteric under the treatment with the estrogen-gestagen combination Ovosiston].
Müller W; Bonow A; Klinger G; Hempel E
Zentralbl Gynakol; 1969 Jul; 91(27):867-73. PubMed ID: 4188685
[No Abstract] [Full Text] [Related]
4. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
Ebeling K; Kühndel K; Rothe K; Canzler E
Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1275-8. PubMed ID: 4111418
[No Abstract] [Full Text] [Related]
5. [Medical therapy of acne vulgaris].
Naerup JG
Tidsskr Nor Laegeforen; 1968 Apr; 88(7):650. PubMed ID: 4175244
[No Abstract] [Full Text] [Related]
6. [Hormonal therapy of acne vulgaris. Ovulation inhibitors in premenstrual acne].
Schirren C; Immel L
Munch Med Wochenschr; 1969 Aug; 111(35):1742-7. PubMed ID: 4185512
[No Abstract] [Full Text] [Related]
7. [Treatment of seborrheic conditions of the female scalp using modern combined peroral estrogen-gestagen preparations].
Spirov G; Berova N; Vasilev D
Vestn Dermatol Venerol; 1973 Jul; 47(7):30-3. PubMed ID: 4127925
[No Abstract] [Full Text] [Related]
8. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
Bernard I
Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
[No Abstract] [Full Text] [Related]
9. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
Kalchauer B
Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
[No Abstract] [Full Text] [Related]
10. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations].
Göretzlehner G; Wilken H
Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480
[TBL] [Abstract][Full Text] [Related]
11. [New possibilities in the conservative treatment of nasopharyngeal angiofibroma].
Mülfay M; Draşoveanu C; Mülfay G; Florea C; Rodean A
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1982; 27(4):247-53. PubMed ID: 6192468
[No Abstract] [Full Text] [Related]
12. Behçet's disease. Alleviation of buccal and genital ulceration by an oral contraceptive agent.
Hewitt AB
Br J Vener Dis; 1971 Feb; 47(1):52-3. PubMed ID: 4101407
[No Abstract] [Full Text] [Related]
13. [Therapeutic significance of the sequential estrogen-gestagen preparation "Ovara" in gynecologic endocrinology].
Prudan R; Durdević LJ; Lekin M
Med Pregl; 1977; 30(11-12):585-93. PubMed ID: 607143
[No Abstract] [Full Text] [Related]
14. Evaluation of a new sequential contraceptive agent.
Parkinson RW; McQuarrie HG; Ellsworth HS; Stone RA
Obstet Gynecol; 1966 Aug; 28(2):239-46. PubMed ID: 4161460
[No Abstract] [Full Text] [Related]
15. [Contraceptives, application and side effects from the dermatological viewpoint].
Schäfer I
Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204
[No Abstract] [Full Text] [Related]
16. [Effect of mestranol and chlormadinone acetate on HGH secretion in Turner's syndrome].
Rudolf K; Kunkel S; Woltanski KP
Zentralbl Gynakol; 1985; 107(23):1454-9. PubMed ID: 2420102
[TBL] [Abstract][Full Text] [Related]
17. [Hormone analytic studies during therapy with new contraceptive agents].
Tenhaeff D
Geburtshilfe Frauenheilkd; 1971 Aug; 31(8):760-7. PubMed ID: 4105805
[No Abstract] [Full Text] [Related]
18. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
Müller R; Kempf HJ; Eckert L
Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
[No Abstract] [Full Text] [Related]
19. [Colposcopic, cytologic and histologic findings on the portio in contraceptive therapy using Ovosiston].
Kaiser P
Zentralbl Gynakol; 1970 Mar; 92(13):401-4. PubMed ID: 4104841
[No Abstract] [Full Text] [Related]
20. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
Jacobs C; Heinen G; Schmal E
Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
